Neuralink: startup founded by Elon Musk will enable a human to see for the first time

Neuralink, founded by Elon Musk, has been one of the most promising and innovative technologies in recent years.

Recently, the company reached a significant milestone with the launch of the Blindsight device, which has the potential to transform the lives of blind individuals.

Blindsight: what it is and how it works

Blindsight is a brain implant that uses an array of microelectrodes inserted into the brain's visual cortex.

This device captures visual signals from an external camera and converts them into electrical impulses that stimulate the patient's visual neurons.

This allows blind individuals, whose visual cortex remains intact, to experience visual phenomena, even if they currently have no functional vision.

Impact on medicine

The FDA (Food and Drug Administration) designation of Blindsight as a device of significant health impact highlights its importance and potential to treat diseases that are currently considered incurable.

The ability to restore vision, even in a limited capacity, represents a monumental advancement in neuroscience and medicine.

Parallels with rocket development

While Neuralink advances in neuroscience, Elon Musk has also been a central figure in the development of space technologies.

Recently, SpaceX, another company led by Musk, achieved a historic feat by catching the Super Heavy booster of its Starship rocket during a flight test – creating a new category in space exploration: a fully reusable rocket system, which is essential for future missions to the Moon and Mars, for example.

Neuralink and its innovations, such as Blindsight, have the potential to revolutionize medicine by treating neurological conditions and improving the quality of life for many people.

The partnership between technological advancements and neuroscience promises a future full of transformative possibilities.